22/09/2019 6:36 am Welcome to isteroids.com - BLOG

Wednesday 07, Jul 2010

  Potential treatment for hay fever and asthma identified

Posted By
Pin it Share on Tumblr

Potential treatment for hay fever and asthma identifiedA potential drug has been identified and about to undergo trials in humans for treating hay fever and asthma.

The drug, RPL554, apparently has the ability to effectively treat respiratory diseases and does not lead to side effects that are usually common characteristics of many of the currently used medications.

It was remarked by Dr. Clive Page, chairman of Verona Pharma, which is developing the treatment, that his company is also ascertaining other novel compounds to tackle respiratory diseases on the lines of anti-inflammatory substances found in starfish and a treatment for coughs.

Thursday 01, Jul 2010

  Hay fever patients could be treated with steroid nasal sprays

Posted By
Pin it Share on Tumblr

Hay fever patients could be treated with steroid nasal spraysA research has suggested that fluticasone propionate (Flonase), a corticosteroid nasal spray, is superior to a combination of popular anti-allergy drugs loratidine (Claritin) and montelukast (Singulair) for managing seasonal allergies.

It was remarked by Robert Naclerio, M.D., professor of surgery at the University of Chicago and director of the study that inflammation measures were significantly better for patients afflicted with hay fever and treated with fluticasone propionate.

This finding by researchers from University of Chicago was presented at the 58th annual meeting of the American Academy of Allergy, Asthma and Immunology.

Thursday 13, May 2010

  Once a day treatment with RPL554 for asthma and hay fever patients

Posted By
Pin it Share on Tumblr

Once a day treatment with RPL554 for asthma and hay fever patientsA new drug, RPL554, was recently found to be effective in treating asthma and hay fever and is about to undergo trials in humans.

The drug, apparently, has the capability of effectively treating respiratory diseases and is without side effects that are regular features with many of the presently available drugs.

Dr. Clive Page, chairman of Verona Pharma, which is developing the treatment, said that the company is also evaluating other novel compounds for tackling respiratory diseases based on anti-inflammatory substances found in starfish and a treatment for coughs.

Tuesday 06, Apr 2010

  Corticosteroid Nasal spray useful for treating hay fever

Posted By
Pin it Share on Tumblr

Corticosteroid Nasal spray useful for treating hay feverA corticosteroid nasal spray, fluticasone propionate (Flonase), was found to be an effective option for controlling seasonal allergies when compared to a combination of popular anti-allergy drugs loratidine (Claritin) and montelukast (Singulair), as per researchers from the University of Chicago.

The study was presented at the 58th annual meeting of the American Academy of Allergy, Asthma and Immunology.

Robert Naclerio, M.D., professor of surgery at the University of Chicago and director of the study, said that inflammation measures were significantly better for patients with hay fever taking fluticasone propionate. It was also said that fluticasone may be a better first choice for treating seasonal allergic rhinitis because of its benefits and low cost.

Sunday 14, Mar 2010

  Hay fever and asthmatic patients can expect miracle relief

Posted By
Pin it Share on Tumblr

Hay fever and asthmatic patients can expect miracle reliefHay fever and asthma patients can expect a good surprise in the times to come if a new drug, RPL554, is able to live up to expectations of effectively treating respiratory diseases but without many of the side-effects most presently-available drugs produce.

The trial to check efficacy of RPL554 started in November 2009 and is expected to be completed by this summer.

According to Dr. Clive Page, chairman of Verona Pharma and a professor of pharmacology at King’s College London, RPL554 is the sole molecule expected to have a low side effect profile. Once-a-day treatment with it can provide significant relief to asthma and hay fever patients.

Thursday 04, Feb 2010

  Trials in line for potential asthma drug

Posted By
Pin it Share on Tumblr

Trials in line for potential asthma drugRPL554, a potential drug for providing relief to patients suffering from asthma is undergoing human trials in the near future after it successfully cleared trials on more than 60 people in the year 2008 at the Centre for Human Drug Research (CHDR) in the Netherlands.

The drug is believed to offer a crucial insight to medical practitioners across the globe to treat asthmatic patients. This potential drug for asthma is expected to reach the market in the next 3-5 years after successful completion of initial trials for safety and efficacy.

Some practitioners are of the view that this drug will help them to draw new and improved treatment plans for treating their asthmatic patients.

Wednesday 18, Nov 2009

  New Asthma Drug heading for Human Trials

Posted By
Pin it Share on Tumblr

New Asthma Drug heading for Human TrialsRPL554, a new drug for treating asthma, that faced trial at the Centre for Human Drug Research (CHDR) in the Netherlands on more than 60 people in 2008, is now expected to head for human trials during 2009.

The drug, which is hailed by some as nothing short of a miracle drug, may prove beneficial to 1.5 million people in the United States alone suffering from asthma and hay fever. This drug is expected to be available in the market in the coming three to four years pending to the success of initial trials for efficacy and safety.

Some researchers are of the view that this once-a-day asthma treatment option would act as a potential first-line therapy for curing patients suffering from asthma and hay fever. This will also mean that patients with asthma would now require only a single needle puff from their “lifesaving” inhalers to stop the symptoms.

Wednesday 14, Oct 2009

  New drug for asthma treatment heads for human trials

Posted By
Pin it Share on Tumblr

New drug for asthma treatment heads for human trialsA new drug, RPL554, which faced trial at the Centre for Human Drug Research (CHDR) in the Netherlands on as many as 60 people in 2008, is expected to be completed by the summer of 2009.

This drug is aimed at treating asthma, which affects more than 1.5 million people in the United States alone, and hay fever. It is believed that the drug could be made available in approximately three to four years if the initial trials for safety and efficacy are found to be successful.

 

It is considered by many researchers that this once-a-day treatment option will be regarded as a potential breakthrough when it comes to treating asthma and hay fever. The treatment option would bring relief to asthma sufferers and its use would mean that asthmatic people would be requiring only a single needle puff from their “lifesaving” inhalers to stop the symptoms.

Tuesday 23, Jun 2009

  Steroid Nasal Spray Effective against Hay Fever

Posted By
Pin it Share on Tumblr

Steroid Nasal Spray Effective against Hay FeverResearchers from the University of Chicago have found that fluticasone propionate (Flonase), a corticosteroid nasal spray, is more effective than a combination of popular anti-allergy drugs loratidine (Claritin) and montelukast (Singulair) when it comes to controlling seasonal allergies.

The findings of this study were presented at the 58th annual meeting of the American Academy of Allergy, Asthma and Immunology.

Robert Naclerio, M.D., professor of surgery at the University of Chicago and director of the study, remarked that the measures of inflammation were considerably better for Hay fever patients who were taking fluticasone propionate.

During the study, it was found that the use of nasal spray results in fewer eosinophils in patients’ nasal passages and patients using steroid nasal sprays displayed minimal side-effects and had lower levels of eosinophil cationic protein, an inflammation sign.

Naclerio remarked that fluticasone may be a better first choice for the treatment of seasonal allergic rhinitis because of its benefits and low cost.

Thursday 23, Apr 2009

  SINOL-M CAN REDUCE HAY FEVER SYMPTOMS EFFECTIVELY, STUDY SUGGESTS

Posted By
Pin it Share on Tumblr

SINOL-M CAN REDUCE HAY FEVER SYMPTOMS EFFECTIVELY, STUDY SUGGESTSAccording to results of a clinical study, hot pepper nasal spray can reduce hay fever. It was reported that a second-generation natural nose spray named Sinol-M, whose main ingredient capsaicin, might effectively relieve stubborn nasal allergies. The study results were presented at the 47th annual meeting of the Western Society of Allergy, Asthma and Immunology in Maui, Hawaii.

CEO of Strategic BioSciences, Dr. Christos Efessiou said that the study had proved for the first time that a homeopathic nasal spray containing capsaicin was effective in the treatment of allergic rhinitis. Principal investigator, Dr. Martha White of the Institute for Asthma and Allergy in Maryland added, “Unlike the prescription nasal steroid sprays, this is an all-natural product that has now been demonstrated to provide clinical benefit and is available without a prescription.”

During the study period of a week, the research team gave Sinol-M and Sinol, predecessor of the former one, to 24 people, aged 13 and older, suffering with hay fever. The team instructed them to use one spray in each nostril as needed up to 12 times a day. After the “washout” period of a week, they crossed over the other formulation.

The results showed that both, Sinol-M and Sinol reduced nasal allergy symptoms, like runny nose, itchy nose, stuffy nose and sneezing, more in comparison to pre-treatment and washout periods. However, the researchers found that relief symptoms of hay fever were achieved more with fewer sprays of Sinol-M than its predecessor, especially at night.

The study was supported by a research grant from Strategic BioSciences, the District of Columbia-based company that has licensed its patented mucoadhesive technology to Sinol USA for the development of Sinol-M.